img

Global Enasidenib Drugs Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Enasidenib Drugs Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
The global Enasidenib Drugs market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Enasidenib Drugs is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Enasidenib Drugs is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Enasidenib Drugs is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Enasidenib Drugs include Celgene Corporation. etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Enasidenib Drugs, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Enasidenib Drugs by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Enasidenib Drugs market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Enasidenib Drugs market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Celgene Corporation
By Type
50mg
100mg
By Application
Hospital
Pharmacy
Sales by Region
North America
the United States
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
UK
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Enasidenib Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Enasidenib Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Enasidenib Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Enasidenib Drugs Definition
1.2 Market by Type
1.2.1 Global Enasidenib Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 50mg
1.2.3 100mg
1.3 Market Segment by Application
1.3.1 Global Enasidenib Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Enasidenib Drugs Sales
2.1 Global Enasidenib Drugs Revenue Estimates and Forecasts 2018-2034
2.2 Global Enasidenib Drugs Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Enasidenib Drugs Revenue by Region
2.3.1 Global Enasidenib Drugs Revenue by Region (2018-2024)
2.3.2 Global Enasidenib Drugs Revenue by Region (2024-2034)
2.4 Global Enasidenib Drugs Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Enasidenib Drugs Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Enasidenib Drugs Sales Quantity by Region
2.6.1 Global Enasidenib Drugs Sales Quantity by Region (2018-2024)
2.6.2 Global Enasidenib Drugs Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Enasidenib Drugs Sales Quantity by Manufacturers
3.1.1 Global Enasidenib Drugs Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Enasidenib Drugs Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Enasidenib Drugs Sales in 2022
3.2 Global Enasidenib Drugs Revenue by Manufacturers
3.2.1 Global Enasidenib Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Enasidenib Drugs Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Enasidenib Drugs Revenue in 2022
3.3 Global Enasidenib Drugs Sales Price by Manufacturers
3.4 Global Key Players of Enasidenib Drugs, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Enasidenib Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Enasidenib Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Enasidenib Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Enasidenib Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Enasidenib Drugs Sales Quantity by Type
4.1.1 Global Enasidenib Drugs Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Enasidenib Drugs Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Enasidenib Drugs Sales Quantity Market Share by Type (2018-2034)
4.2 Global Enasidenib Drugs Revenue by Type
4.2.1 Global Enasidenib Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Enasidenib Drugs Forecasted Revenue by Type (2024-2034)
4.2.3 Global Enasidenib Drugs Revenue Market Share by Type (2018-2034)
4.3 Global Enasidenib Drugs Price by Type
4.3.1 Global Enasidenib Drugs Price by Type (2018-2024)
4.3.2 Global Enasidenib Drugs Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Enasidenib Drugs Sales Quantity by Application
5.1.1 Global Enasidenib Drugs Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Enasidenib Drugs Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Enasidenib Drugs Sales Quantity Market Share by Application (2018-2034)
5.2 Global Enasidenib Drugs Revenue by Application
5.2.1 Global Enasidenib Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global Enasidenib Drugs Forecasted Revenue by Application (2024-2034)
5.2.3 Global Enasidenib Drugs Revenue Market Share by Application (2018-2034)
5.3 Global Enasidenib Drugs Price by Application
5.3.1 Global Enasidenib Drugs Price by Application (2018-2024)
5.3.2 Global Enasidenib Drugs Price Forecast by Application (2024-2034)
6 North America
6.1 North America Enasidenib Drugs Sales by Company
6.1.1 North America Enasidenib Drugs Revenue by Company (2018-2024)
6.1.2 North America Enasidenib Drugs Sales Quantity by Company (2018-2024)
6.2 North America Enasidenib Drugs Market Size by Type
6.2.1 North America Enasidenib Drugs Sales Quantity by Type (2018-2034)
6.2.2 North America Enasidenib Drugs Revenue by Type (2018-2034)
6.3 North America Enasidenib Drugs Market Size by Application
6.3.1 North America Enasidenib Drugs Sales Quantity by Application (2018-2034)
6.3.2 North America Enasidenib Drugs Revenue by Application (2018-2034)
6.4 North America Enasidenib Drugs Market Size by Country
6.4.1 North America Enasidenib Drugs Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Enasidenib Drugs Revenue by Country (2018-2034)
6.4.3 North America Enasidenib Drugs Sales Quantity by Country (2018-2034)
6.4.4 the United States
6.4.5 Canada
7 Europe
7.1 Europe Enasidenib Drugs Sales by Company
7.1.1 Europe Enasidenib Drugs Sales Quantity by Company (2018-2024)
7.1.2 Europe Enasidenib Drugs Revenue by Company (2018-2024)
7.2 Europe Enasidenib Drugs Market Size by Type
7.2.1 Europe Enasidenib Drugs Sales Quantity by Type (2018-2034)
7.2.2 Europe Enasidenib Drugs Revenue by Type (2018-2034)
7.3 Europe Enasidenib Drugs Market Size by Application
7.3.1 Europe Enasidenib Drugs Sales Quantity by Application (2018-2034)
7.3.2 Europe Enasidenib Drugs Revenue by Application (2018-2034)
7.4 Europe Enasidenib Drugs Market Size by Country
7.4.1 Europe Enasidenib Drugs Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Enasidenib Drugs Revenue by Country (2018-2034)
7.4.3 Europe Enasidenib Drugs Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 UK
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Enasidenib Drugs Sales by Company
8.1.1 China Enasidenib Drugs Sales Quantity by Company (2018-2024)
8.1.2 China Enasidenib Drugs Revenue by Company (2018-2024)
8.2 China Enasidenib Drugs Market Size by Type
8.2.1 China Enasidenib Drugs Sales Quantity by Type (2018-2034)
8.2.2 China Enasidenib Drugs Revenue by Type (2018-2034)
8.3 China Enasidenib Drugs Market Size by Application
8.3.1 China Enasidenib Drugs Sales Quantity by Application (2018-2034)
8.3.2 China Enasidenib Drugs Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Enasidenib Drugs Sales by Company
9.1.1 APAC Enasidenib Drugs Sales Quantity by Company (2018-2024)
9.1.2 APAC Enasidenib Drugs Revenue by Company (2018-2024)
9.2 APAC Enasidenib Drugs Market Size by Type
9.2.1 APAC Enasidenib Drugs Sales Quantity by Type (2018-2034)
9.2.2 APAC Enasidenib Drugs Revenue by Type (2018-2034)
9.3 APAC Enasidenib Drugs Market Size by Application
9.3.1 APAC Enasidenib Drugs Sales Quantity by Application (2018-2034)
9.3.2 APAC Enasidenib Drugs Revenue by Application (2018-2034)
9.4 APAC Enasidenib Drugs Market Size by Region
9.4.1 APAC Enasidenib Drugs Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Enasidenib Drugs Revenue by Region (2018-2034)
9.4.3 APAC Enasidenib Drugs Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Enasidenib Drugs Sales by Company
10.1.1 Middle East, Africa and Latin America Enasidenib Drugs Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Enasidenib Drugs Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Enasidenib Drugs Market Size by Type
10.2.1 Middle East, Africa and Latin America Enasidenib Drugs Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Enasidenib Drugs Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Enasidenib Drugs Market Size by Application
10.3.1 Middle East, Africa and Latin America Enasidenib Drugs Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Enasidenib Drugs Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Enasidenib Drugs Market Size by Country
10.4.1 Middle East, Africa and Latin America Enasidenib Drugs Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Enasidenib Drugs Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Enasidenib Drugs Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Celgene Corporation
11.1.1 Celgene Corporation Company Information
11.1.2 Celgene Corporation Overview
11.1.3 Celgene Corporation Enasidenib Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Celgene Corporation Enasidenib Drugs Products and Services
11.1.5 Celgene Corporation Enasidenib Drugs SWOT Analysis
11.1.6 Celgene Corporation Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Enasidenib Drugs Value Chain Analysis
12.2 Enasidenib Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Enasidenib Drugs Production Mode & Process
12.4 Enasidenib Drugs Sales and Marketing
12.4.1 Enasidenib Drugs Sales Channels
12.4.2 Enasidenib Drugs Distributors
12.5 Enasidenib Drugs Customers
13 Market Dynamics
13.1 Enasidenib Drugs Industry Trends
13.2 Enasidenib Drugs Market Drivers
13.3 Enasidenib Drugs Market Challenges
13.4 Enasidenib Drugs Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Enasidenib Drugs Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of 50mg
Table 3. Major Manufacturers of 100mg
Table 4. Global Enasidenib Drugs Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Enasidenib Drugs Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Enasidenib Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Enasidenib Drugs Revenue Market Share by Region (2018-2024)
Table 8. Global Enasidenib Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Enasidenib Drugs Revenue Market Share by Region (2024-2034)
Table 10. Global Enasidenib Drugs Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 11. Global Enasidenib Drugs Sales by Region (2018-2024) & (K Units)
Table 12. Global Enasidenib Drugs Sales Market Share by Region (2018-2024)
Table 13. Global Enasidenib Drugs Sales by Region (2024-2034) & (K Units)
Table 14. Global Enasidenib Drugs Sales Market Share by Region (2024-2034)
Table 15. Global Enasidenib Drugs Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 16. Global Enasidenib Drugs Sales Quantity Share by Manufacturers (2018-2024)
Table 17. Global Enasidenib Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Enasidenib Drugs Revenue Share by Manufacturers (2018-2024)
Table 19. Global Enasidenib Drugs Price by Manufacturers 2018-2024 (USD/Unit)
Table 20. Global Key Players of Enasidenib Drugs, Industry Ranking, 2021 VS 2022
Table 21. Global Enasidenib Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Enasidenib Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Enasidenib Drugs as of 2022)
Table 23. Global Key Manufacturers of Enasidenib Drugs, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Enasidenib Drugs, Product Offered and Application
Table 25. Global Key Manufacturers of Enasidenib Drugs, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Enasidenib Drugs Sales Quantity by Type (2018-2024) & (K Units)
Table 28. Global Enasidenib Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 29. Global Enasidenib Drugs Sales Quantity Share by Type (2018-2024)
Table 30. Global Enasidenib Drugs Sales Quantity Share by Type (2024-2034)
Table 31. Global Enasidenib Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Enasidenib Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Enasidenib Drugs Revenue Share by Type (2018-2024)
Table 34. Global Enasidenib Drugs Revenue Share by Type (2024-2034)
Table 35. Enasidenib Drugs Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Enasidenib Drugs Price Forecast by Type (2024-2034) & (USD/Unit)
Table 37. Global Enasidenib Drugs Sales Quantity by Application (2018-2024) & (K Units)
Table 38. Global Enasidenib Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 39. Global Enasidenib Drugs Sales Quantity Share by Application (2018-2024)
Table 40. Global Enasidenib Drugs Sales Quantity Share by Application (2024-2034)
Table 41. Global Enasidenib Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Enasidenib Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Enasidenib Drugs Revenue Share by Application (2018-2024)
Table 44. Global Enasidenib Drugs Revenue Share by Application (2024-2034)
Table 45. Enasidenib Drugs Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Enasidenib Drugs Price Forecast by Application (2024-2034) & (USD/Unit)
Table 47. North America Enasidenib Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 48. North America Enasidenib Drugs Sales Quantity by Company (2018-2024) & (K Units)
Table 49. North America Enasidenib Drugs Sales Quantity by Type (2018-2024) & (K Units)
Table 50. North America Enasidenib Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 51. North America Enasidenib Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 52. North America Enasidenib Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Enasidenib Drugs Sales Quantity by Application (2018-2024) & (K Units)
Table 54. North America Enasidenib Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 55. North America Enasidenib Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 56. North America Enasidenib Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Enasidenib Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. North America Enasidenib Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 59. North America Enasidenib Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Enasidenib Drugs Sales Quantity by Country (2018-2024) & (K Units)
Table 61. North America Enasidenib Drugs Sales Quantity by Country (2024-2034) & (K Units)
Table 62. Europe Enasidenib Drugs Sales Quantity by Company (2018-2024) & (K Units)
Table 63. Europe Enasidenib Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 64. Europe Enasidenib Drugs Sales Quantity by Type (2018-2024) & (K Units)
Table 65. Europe Enasidenib Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 66. Europe Enasidenib Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Enasidenib Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Enasidenib Drugs Sales Quantity by Application (2018-2024) & (K Units)
Table 69. Europe Enasidenib Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 70. Europe Enasidenib Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Enasidenib Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Enasidenib Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 73. Europe Enasidenib Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Enasidenib Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Enasidenib Drugs Sales Quantity by Country (2018-2024) & (K Units)
Table 76. Europe Enasidenib Drugs Sales Quantity by Country (2024-2034) & (K Units)
Table 77. China Enasidenib Drugs Sales Quantity by Company (2018-2024) & (K Units)
Table 78. China Enasidenib Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 79. China Enasidenib Drugs Sales Quantity by Type (2018-2024) & (K Units)
Table 80. China Enasidenib Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 81. China Enasidenib Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 82. China Enasidenib Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Enasidenib Drugs Sales Quantity by Application (2018-2024) & (K Units)
Table 84. China Enasidenib Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 85. China Enasidenib Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 86. China Enasidenib Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Enasidenib Drugs Sales Quantity by Company (2018-2024) & (K Units)
Table 88. APAC Enasidenib Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 89. APAC Enasidenib Drugs Sales Quantity by Type (2018-2024) & (K Units)
Table 90. APAC Enasidenib Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 91. APAC Enasidenib Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 92. APAC Enasidenib Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Enasidenib Drugs Sales Quantity by Application (2018-2024) & (K Units)
Table 94. APAC Enasidenib Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 95. APAC Enasidenib Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 96. APAC Enasidenib Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Enasidenib Drugs Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 98. APAC Enasidenib Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 99. APAC Enasidenib Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Enasidenib Drugs Sales Quantity by Region (2018-2024) & (K Units)
Table 101. APAC Enasidenib Drugs Sales Quantity by Region (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America Enasidenib Drugs Sales Quantity by Company (2018-2024) & (K Units)
Table 103. Middle East, Africa and Latin America Enasidenib Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Enasidenib Drugs Sales Quantity by Type (2018-2024) & (K Units)
Table 105. Middle East, Africa and Latin America Enasidenib Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 106. Middle East, Africa and Latin America Enasidenib Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Enasidenib Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Enasidenib Drugs Sales Quantity by Application (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Enasidenib Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 110. Middle East, Africa and Latin America Enasidenib Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Enasidenib Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Enasidenib Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Enasidenib Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Enasidenib Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Enasidenib Drugs Sales Quantity by Country (2018-2024) & (K Units)
Table 116. Middle East, Africa and Latin America Enasidenib Drugs Sales Quantity by Country (2024-2034) & (K Units)
Table 117. Celgene Corporation Company Information
Table 118. Celgene Corporation Description and Overview
Table 119. Celgene Corporation Enasidenib Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 120. Celgene Corporation Enasidenib Drugs Product and Services
Table 121. Celgene Corporation Enasidenib Drugs SWOT Analysis
Table 122. Celgene Corporation Recent Developments
Table 123. Key Raw Materials Lists
Table 124. Raw Materials Key Suppliers Lists
Table 125. Enasidenib Drugs Distributors List
Table 126. Enasidenib Drugs Customers List
Table 127. Enasidenib Drugs Market Trends
Table 128. Enasidenib Drugs Market Drivers
Table 129. Enasidenib Drugs Market Challenges
Table 130. Enasidenib Drugs Market Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Enasidenib Drugs Product Picture
Figure 2. Global Enasidenib Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Enasidenib Drugs Market Share by Type in 2022 & 2034
Figure 4. 50mg Product Picture
Figure 5. 100mg Product Picture
Figure 6. Global Enasidenib Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Enasidenib Drugs Market Share by Application in 2022 & 2034
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Enasidenib Drugs Report Years Considered
Figure 11. Global Enasidenib Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 12. Global Enasidenib Drugs Revenue 2018-2034 (US$ Million)
Figure 13. Global Enasidenib Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 14. Global Enasidenib Drugs Sales Quantity 2018-2034 (K Units)
Figure 15. Global Enasidenib Drugs Sales Quantity Market Share by Region (2018-2024)
Figure 16. Global Enasidenib Drugs Sales Quantity Market Share by Region (2024-2034)
Figure 17. North America Enasidenib Drugs Sales Quantity YoY (2018-2034) & (K Units)
Figure 18. North America Enasidenib Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 19. Europe Enasidenib Drugs Sales Quantity YoY (2018-2034) & (K Units)
Figure 20. Europe Enasidenib Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 21. China Enasidenib Drugs Sales Quantity YoY (2018-2034) & (K Units)
Figure 22. China Enasidenib Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 23. APAC Enasidenib Drugs Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. APAC Enasidenib Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Enasidenib Drugs Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. Middle East, Africa and Latin America Enasidenib Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Enasidenib Drugs Sales Quantity in 2022
Figure 28. The Top 10 and Top 5 Players Market Share by Enasidenib Drugs Revenue in 2022
Figure 29. Enasidenib Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Enasidenib Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 31. Global Enasidenib Drugs Revenue Market Share by Type (2018-2034)
Figure 32. Global Enasidenib Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 33. Global Enasidenib Drugs Revenue Market Share by Application (2018-2034)
Figure 34. North America Enasidenib Drugs Revenue Market Share by Company in 2022
Figure 35. North America Enasidenib Drugs Sales Quantity Market Share by Company in 2022
Figure 36. North America Enasidenib Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 37. North America Enasidenib Drugs Revenue Market Share by Type (2018-2034)
Figure 38. North America Enasidenib Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 39. North America Enasidenib Drugs Revenue Market Share by Application (2018-2034)
Figure 40. North America Enasidenib Drugs Revenue Share by Country (2018-2034)
Figure 41. North America Enasidenib Drugs Sales Quantity Share by Country (2018-2034)
Figure 42. the United States Enasidenib Drugs Revenue (2018-2034) & (US$ Million)
Figure 43. Canada Enasidenib Drugs Revenue (2018-2034) & (US$ Million)
Figure 44. Europe Enasidenib Drugs Sales Quantity Market Share by Company in 2022
Figure 45. Europe Enasidenib Drugs Revenue Market Share by Company in 2022
Figure 46. Europe Enasidenib Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 47. Europe Enasidenib Drugs Revenue Market Share by Type (2018-2034)
Figure 48. Europe Enasidenib Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 49. Europe Enasidenib Drugs Revenue Market Share by Application (2018-2034)
Figure 50. Europe Enasidenib Drugs Revenue Share by Country (2018-2034)
Figure 51. Europe Enasidenib Drugs Sales Quantity Share by Country (2018-2034)
Figure 52. Germany Enasidenib Drugs Revenue (2018-2034) & (US$ Million)
Figure 53. France Enasidenib Drugs Revenue (2018-2034) & (US$ Million)
Figure 54. UK Enasidenib Drugs Revenue (2018-2034) & (US$ Million)
Figure 55. Italy Enasidenib Drugs Revenue (2018-2034) & (US$ Million)
Figure 56. Russia Enasidenib Drugs Revenue (2018-2034) & (US$ Million)
Figure 57. China Enasidenib Drugs Sales Quantity Market Share by Company in 2022
Figure 58. China Enasidenib Drugs Revenue Market Share by Company in 2022
Figure 59. China Enasidenib Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 60. China Enasidenib Drugs Revenue Market Share by Type (2018-2034)
Figure 61. China Enasidenib Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 62. China Enasidenib Drugs Revenue Market Share by Application (2018-2034)
Figure 63. APAC Enasidenib Drugs Sales Quantity Market Share by Company in 2022
Figure 64. APAC Enasidenib Drugs Revenue Market Share by Company in 2022
Figure 65. APAC Enasidenib Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 66. APAC Enasidenib Drugs Revenue Market Share by Type (2018-2034)
Figure 67. APAC Enasidenib Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 68. APAC Enasidenib Drugs Revenue Market Share by Application (2018-2034)
Figure 69. APAC Enasidenib Drugs Revenue Share by Region (2018-2034)
Figure 70. APAC Enasidenib Drugs Sales Quantity Share by Region (2018-2034)
Figure 71. Japan Enasidenib Drugs Revenue (2018-2034) & (US$ Million)
Figure 72. South Korea Enasidenib Drugs Revenue (2018-2034) & (US$ Million)
Figure 73. China Taiwan Enasidenib Drugs Revenue (2018-2034) & (US$ Million)
Figure 74. Southeast Asia Enasidenib Drugs Revenue (2018-2034) & (US$ Million)
Figure 75. India Enasidenib Drugs Revenue (2018-2034) & (US$ Million)
Figure 76. Middle East, Africa and Latin America Enasidenib Drugs Sales Quantity Market Share by Company in 2022
Figure 77. Middle East, Africa and Latin America Enasidenib Drugs Revenue Market Share by Company in 2022
Figure 78. Middle East, Africa and Latin America Enasidenib Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 79. Middle East, Africa and Latin America Enasidenib Drugs Revenue Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Enasidenib Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 81. Middle East, Africa and Latin America Enasidenib Drugs Revenue Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Enasidenib Drugs Sales Quantity Share by Country (2018-2034)
Figure 83. Middle East, Africa and Latin America Enasidenib Drugs Revenue Share by Country (2018-2034)
Figure 84. Brazil Enasidenib Drugs Revenue (2018-2034) & (US$ Million)
Figure 85. Mexico Enasidenib Drugs Revenue (2018-2034) & (US$ Million)
Figure 86. Turkey Enasidenib Drugs Revenue (2018-2034) & (US$ Million)
Figure 87. Israel Enasidenib Drugs Revenue (2018-2034) & (US$ Million)
Figure 88. GCC Countries Enasidenib Drugs Revenue (2018-2034) & (US$ Million)
Figure 89. Enasidenib Drugs Value Chain
Figure 90. Enasidenib Drugs Production Process
Figure 91. Channels of Distribution (Direct Vs Distribution)
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed